Ligand-activated Flpe for temporally regulated gene modifications

Genesis (United States)

Volumn 41, Issue 3, 2005, Pages 99-109

  Hunter, Nina L ^a   Awatramani, Rajeshwar B ^a   Farley, Francis W ^a   Dymecki, Susan M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Flpe; Induction; Recombinase; Tamoxifen

Indexed keywords

CRE RECOMBINASE; ESTROGEN RECEPTOR; FLIPPASE RECOMBINASE; GENE PRODUCT; HYBRID PROTEIN; LIGAND; STEROID RECEPTOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL SELECTION; CONTROLLED STUDY; DNA MODIFICATION; DNA RECOMBINATION; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FUSION GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE INDUCTION; GENETIC ENGINEERING; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 17044404727     PISSN: 1526954X     EISSN: None     Source Type: Journal    
DOI: 10.1002/gene.20101     Document Type: Article

References (36)

1. Ahn S, Joyner AL. 2004. Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning. Cell 118:505-516.
2. Awatramani R, Soriano P, Mai JJ, Dymecki SM. 2001. A FLP indicator strain, R26::FRAP, driving alkaline phosphatase expression from the ROSA26 locus. Nat Genet 29:257-259.
3. Awatramani R, Soriano P, Rodriguez CI, Mai JJ, Dymecki SM. 2003. Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation. Nat Genet 35:70-75.
4. Bao ZZ, Cepko CL. 1997. The expression and function of Notch pathway genes in the developing rat eye. J Neurosci 17:1425-1434.
5. Bohen SP, Yamamoto KR. 1993. Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc Natl Acad Sci U S A 90:11424-11428.
6. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D. 1997. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci U S A 94:14559-14563.
7. Buchholz F, Angrand P-O, Stewart AF. 1998. Improved properties of Flp recombinase evolved by cycling mutagenesis. Nat Biotechnol 16:657-662.
8. Chung JH, Whitely M, Felsenfeld G. 1993. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74:505-514.
9. Chung JH, Bell AC, Felsenfeld G. 1997. Characterization of the chicken B-globin insulator. Proc Natl Acad Sci U S A 94:575-580.
10. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. 1998. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8:1323-1326.
11. Dymecki SM, Tomasiewicz H. 1998. Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse. Dev Biol 201:57-65.
12. Dymecki SM, Rodriguez CI, Awatramani RB. 2002. Switching on lineage tracers using site-specific recombination. In: Turksen K, editor. Embryonic stem cells: methods and protocols. Totowa, NJ: Humana Press.
13. Echelard Y, Vassileva G, McMahon AP. 1994. Cis-acting regulatory sequences governing Wnt-1 expression in the developing mouse CNS. Development 120:2213-2224.
14. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. 1996. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93:10887-10890.
15. Feil R, Wagner J, Metzger D, Chambon P. 1997. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Res Commun 237:752-757.
16. Guo C, Yang W, Lobe CG. 2002. A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action. genesis 32:8-18.
17. Hayashi S, McMahon AP 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244(2):305-18.
18. Hogan B, Beddington R, Costantini F, Lacy E. 1994. Manipulating the mouse embryo, 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press.
19. Imai T, Jiang M, Chambon P. 2001. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (CreERT2) in adipocytes. Proc Natl Acad Sci U S A 98:224-228.
20. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27:4324-4327.
21. Kellendonk C, Tronche F, Monaghan A-P, Angrand P-O, Stewart F, Schutz G. 1996. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res 24:1404-1411.
22. Kimmel RA, Turnbull DH, Blanquet V, Wurst W, Loomis CA, Joyner AL. 2000. Two lineage boundaries coordinate vertebrate apical ectodermal ridge formation. Genes Dev 14:1377-1389.
23. Logie C, Stewart AF. 1995. Ligand-regulated site-specific recombination. Proc Natl Acad Sci U S A 92:5940-5944.
24. Logie C, Nichols M, Myles K, Funder JW, Stewart AF. 1998. Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins. Mol Endocrinol 12:1120-1132.
25. Metzger D, Clifford J, Chiba H, Chambon P 1995. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci U S A 92:6991-6995.
26. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200.
27. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR. 1990. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348:166-168.
28. Riddle RD, Johnson RL, Laufer E, Tabin C. 1993. Sonic hedgehog mediates the polarizing activity of the ZPA. Cell 75:1425-1434.
29. Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, Stewart AF, Dymecki SM. 2000. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 25:139-140.
30. Scherrer LC, Picard D, Massa E, Harmon JM, Simons SJ, Yamamoto KR, Pratt WB. 1993. Evidence that the hormone binding domain of steroid receptors confers hormonal control on chimeric proteins by determining their hormone-regulated binding to heat-shock protein 90. Biochemistry 32:5381-5386.
31. Schwenk F, Kuhn R, Angrand PO, Rajewsky K, Stewart AF. 1998. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res 26:1427-1432.
32. Seibler J, Zevnik B, Kuter-Luks B, Andreas S, Kern H, Hennek T, Rode A, Heimann C, Faust N, Kauselmann G. 2003. Rapid generation of inducible mouse mutants. Nucleic Acids Res 31:e12.
33. Wilkinson DG. 1992. Whole mount in situ hybridization of vertebrate embryos. In: In situ hybridization: a practical approach. Oxford: IRL Press. p 74-83.
34. Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P. 1997. Disruption of overlapping transcripts in the ROSA beta geo 26 trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci U S A 94:3789-3794.
35. Zervas M, Millet S, Ahn S, Joyner AL. 2004. Cell behaviors and genetic lineages of the mesencephalon and rhombomere 1. Neuron 43:345-357.
36. Zirlinger M, Lo L, McMahon AP, Anderson DJ. 2002. Transient expression of the bHLH factor neurogenin-2 marks a subpopulation of neural crest cells biased for a sensory but not a neuronal fate. Proc Natl Acad Sci U S A 99:8084-8089.